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The Editorial on the Research Topic
Bacterial Exotoxins: How Bacteria Fight the Immune System
Upon infection with a bacterial pathogen, the body initiates both innate and adaptive immune 
responses with the ultimate goal to eliminate the invader and to return to homeostasis. Occasionally, 
however, the body may react inadequately, resulting in collateral damage to tissues if the response 
it too strong or in a failure to eradicate the pathogen if the response is too weak or ephemeral. 
Functionally diverse toxins released by bacteria during infection can contribute considerably to the 
outcomes of the immune response. For example, bacterial toxins may mediate bacterial evasion of 
immune recognition, facilitate dwelling within protected niches of eukaryotic cells, or modulate 
pro-inflammatory responses. Furthermore, in recent years, it has become evident that beyond their 
canonical actions, bacterial toxins may initiate other cellular responses. For example, besides induc-
ing cytolysis, pore-forming toxins may also induce autophagy, pyroptosis, or activation of the MAPK 
pathways, resulting in adjustment of the host immune response to infection and modification of 
inflammatory responses both locally and systemically (1, 2).
Exotoxins can be single polypeptides or heteromeric protein complexes that act on different parts 
of the cells. At the cell surface, they may insert into the membrane to cause damage, bind to receptors 
to initiate their uptake, or facilitate interactions with other cell types. For intracellular activity, exo-
toxins need to be translocated across the eukaryotic membrane. Gram-negative bacteria can directly 
inject effector proteins in a receptor-independent manner by use of specialized needle apparatus such 
as bacterial type II, type III, or type IV secretion systems. Other methods of translocation include 
the phagocytic uptake of bacteria followed by toxin secretion and receptor-mediated endocytosis. 
Receptor-based uptake allows the targeting of distinct cell types uniquely expressing the receptor. 
It is initiated by the binding of heteromeric toxin complexes to cell surfaces and is completed by 
the translocation of the effector proteins across the endosomal membrane. Once in the cytosol, 
toxins interact with specific eukaryotic target proteins to cause post-translational modifications of 
host proteins that often result in the manipulation of cellular signaling cascades and inflammatory 
responses (3).
The intention of this special issue on bacterial exotoxins is to gather current knowledge on 
the interaction of these versatile effector proteins with the host immune system and to describe 
mechanisms of immune modification and evasion. We thank the authors of the following 16 articles 
for providing diverse overviews, comprehensive reviews, and intriguing new data regarding the 
effects on, and interactions with, three important groups of immune function: (1) barrier cells such 
as fibroblasts, and epithelial and endothelial cells that are responsible for mediating local immune 
responses, (2) innate phagocytic cells, and (3) cells of the adaptive arm of immunity.
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The first group of manuscripts addresses the interaction of 
bacterial toxins of both Gram-positive and Gram-negative 
bacteria with initial barrier cells. Mayer et al. explore the effects 
of Shiga Toxin (Stx) expressed by enterohemorrhagic E. coli on 
renal endothelial and epithelial cells. In the kidneys, Stx causes 
hemolytic uremic syndrome, which can result in renal failure. 
The authors found that Stx-induced damage of renal cells stimu-
lates the release of host-derived damage-associated molecular 
patterns (DAMPs), such as histones or high-mobility group 
protein B1 (HMGB1), and that these contribute to the severity 
of the disease. Ashida et al. review how Shigella, a pathogen of the 
intestinal tract that causes dysentery, uses effector proteins that 
are injected into host target cells via a type-III secretion system 
to induce cell death, to modulate protein trafficking and signal-
ing, and to ultimately interfere with both innate and adaptive 
immunity. Moreover, the poultry pathogen Salmonella pullorum 
expresses an iron-storage protein called bacterioferritin that 
appears to be a major antigen for the chicken humoral response 
to S. pullorum infection (Xu et al.). Using a chicken fibroblast cell 
line, the authors furthermore identify the induction of the type 
I interferon IFN-β as a major consequence of bacterioferritin 
exposure. The last article on the effects of toxin on host barrier 
function is by von Hoven et al. who studied the pore-forming 
α-toxin of Staphylococcus aureus. Using mouse embryonic 
fibroblasts, the authors show that stress-induced basal phospho-
rylation of the eukaryotic translation initiation factor 2α (eIF2α) 
results in tolerance to the toxin. Macrophages, however, are toler-
ant to α-toxin independent of such a stress response, underlining 
the fact that various host cell types can mediate different layers of 
tolerance and protection.
Phagocytes, such as macrophages, neutrophils, and dendritic 
cells, provide an immediate response and protection during the 
early stages of bacterial invasion. Therefore, many bacterial 
virulence factors and toxins specifically target these innate 
immune cells. Five articles in this special issue review multiple 
aspects of macrophage–toxin interactions. While do Vale et al.  
give a comprehensive overview on how bacteria use toxins as 
weapons to avoid recognition by phagocytes, Barth et al. focus 
on the effects of the toxins C3bot of Clostridium botulinum 
and C3lim of Clostridium limosum, which exclusively target 
monocytes and macrophages to ADP-ribosylate cellular Rho 
GTPases. Because of their cell specificity, the authors propose 
that engineered inactive variants of these two toxins may 
potentially be useful as both therapeutic and molecular tools. 
Greaney et  al. review the various interactions between bacte-
rial exotoxins and the inflammasomes, which are intracellular 
sensors of danger- and pathogen-associated molecular patterns 
and key to the elicitation of immune responses to a number of 
pathogens. An additional review by Simon and Hilbi describes 
how the approximately 300 effector proteins of Legionella pneu-
mophila, the causative agent of legionellosis, help to establish 
a bacterial replication niche in alveolar macrophages. Finally, 
Zhang et al. investigate the effect of a previously uncharacter-
ized protein of Streptococcus suis that signals via activation of 
TLR2, resulting in the production pro-inflammatory cytokines, 
such as IL-1, MCP-1, and TNF-α.
Neutrophils are highly motile phagocytes that, in addition to 
the phagocytic uptake and killing of bacteria, can form neutrophil 
extracellular traps (NETs) to destroy bacteria in a phagocytosis-
independent manner. In a comprehensive mini-review, von 
Köckritz-Blickwede et  al. give an overview on the modulation 
of NET formation by microbial virulence factors. Similarly, 
Uchiyama et al. describe how the pore-forming toxin streptolysin 
O of Streptococcus pyogenes manipulates neutrophil activity and 
renders the bacterium resistant to neutrophil killing by impair-
ing NET formation, extracellular killing, and the oxidative burst 
reaction of neutrophils. Maurer et  al. describe the interesting 
capacity of a bitter receptor expressed on neutrophils to recognize 
bacterial quorum sensing (QS) molecules that bacteria employ 
for bacterial communication. However, the effect of QS molecules 
on host cell signaling is not restricted to neutrophils; Liu et al. 
review how secreted QS molecules of Pseudomonas aeruginosa 
modulate and functionally impair host cells.
Finally, various authors address the interactions of toxins with 
cells of the adaptive immune system. Bacterial superantigens 
simultaneously bind to the T cell receptor and to the MHC class 
II molecule on the surface of antigen-presenting cells (APCs) in 
a non-specific, antigen-independent manner. The crosslinking 
causes a massive activation of T cells, ultimately resulting in 
anergy and the activation of regulatory T cells (Tregs). Krakauer 
et al. review our current knowledge of danger signaling pathways 
in T cells that are induced by the superantigen staphylococcal 
enterotoxin B (SEB) of S. aureus, and they propose appealing 
strategies of how these pathways may be exploited to discover 
novel drug targets. Sähr et al. investigated whether superantigen-
triggered signaling cascades in APCs could provide a microen-
vironment that facilitates the differentiation of Tregs. However, 
some toxins can also manipulate T cell differentiation directly 
and in the absence of an APC. Hildebrand et al. show that the 
Pasteurella multocida Toxin (PMT) can modulate T cell signaling 
through the activation of specific transcription factors, ultimately 
resulting in the differentiation of naive T cells into Th17.
In summary, the articles in this special issue highlight the 
complexity of bacterial toxin interaction with different aspects 
and cells of the immune system. In particular, it becomes appar-
ent that bacteria have developed intricate means to modify 
immune cell functions in a precise, strain-specific, and targeted 
manner, emphasizing the fact that during bacterial infections 
completely different strategies are used by the invading patho-
gen to escape the immune system. In light of the increasing 
occurrences of antibiotic resistances in bacteria observed 
worldwide, research in recent years has therefore focused on 
more targeted solutions to fight and prevent infections, such 
as enhancing host immune functions. A more detailed under-
standing of how bacteria manipulate the immune system may 
help to better understand the disease and to ultimately find 
better therapeutic treatments.
aUtHor CoNtriBUtioNS
All authors listed have made substantial, direct, and intellectual 
contribution to the work and approved it for publication.
3Sastalla et al. Bacterial Exotoxins and Immune Evasion
Frontiers in Immunology | www.frontiersin.org August 2016 | Volume 7 | Article 300
rEFErENCES
1. Gonzalez MR, Bischofberger M, Pernot L, Van Der Goot FG, Freche B. Bacterial 
pore-forming toxins: the (w)hole story? Cell Mol Life Sci (2008) 65:493–507. 
doi:10.1007/s00018-007-7434-y 
2. Los FC, Randis TM, Aroian RV, Ratner AJ. Role of pore-forming toxins in 
bacterial infectious diseases. Microbiol Mol Biol Rev (2013) 77:173–207. 
doi:10.1128/MMBR.00052-12 
3. Ribet D, Cossart P. Post-translational modifications in host cells during bacte-
rial infection. FEBS Lett (2010) 584:2748–58. doi:10.1016/j.febslet.2010.05.012 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Sastalla, Monack and Kubatzky. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (CC 
BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) or licensor are credited and that the original publication 
in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms.
FUNdiNG
This work was in part supported by the Intramural Research 
Program of National Institute of Allergy and Infectious Diseases 
(NIAID) at the National Institutes of Health (NIH), Bethesda, MD, 
USA (IS), a grant from the Deutsche Forschungsgemeinschaft, 
project SPP1468 Immunobone (KK), and by the NIH, grant 
AI095396 (DM).
